Impact of Acute Cocaine Use on Aneurysmal Subarachnoid Hemorrhage
Stroke 44:1825-1829, Chang, T.,et al, 2013
Results of Intravenous Thrombolysis within 4.5 to 6 Hours and Updated Results within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR)
JAMA Neurol 70:837-844, Ahmed, N.,et al, 2013
Comparison of Final Infarct Volumes in Patients who Received Endovascular Therapy or Intravenous Thrombolysis for Acute Intracranial Large-Vessel Occlusions
JAMA Neurol 70:831-836, Rangaraju, S.,et al, 2013
Is Intra-Arterial Thrombolysis Beneficial for M2 Occlusions? Subgroup Analysis of the PROACT-II Trial
Stroke 44:240-242, Rahme, R.,et al, 2013
Density of Thrombus on Admission CT Predicts Revascularization Efficacy in Large Vessel Occlusion Acute Ischemic Stroke
Stroke 44:243-245, Moftakhar, P.,et al, 2013
Prehospital Thrombolysis in Acute Stroke
Neurol 80:163-168, Weber, J.,et al, 2013
An Observational Study of Thrombolysis Outcomes in Wake-Up Ischemic Stroke Patients
Stroke 44:427-431, Manawadu, D.,et al, 2013
Cannabis, Ischemic Stroke, and Transient Ischemic Attack
Stroke 44:2327-2329, Barber, P.A.,et al, 2013
A Case-Controlled Comparison of Thrombolysis Outcomes Between Wake-Up and Known Time of Onset Ischemic Stroke Patients
Stroke 44:2226-2231, Manawadu, D.,et al, 2013
Thrombolysis of Basilar Artery Occlusion: Impact of Baseline Ischemia and Time
Ann Neurol 73:688-694, Strbian, D.,et al, 2013
New Appearance of Extraischemic Microbleeds on T2*-Weighted Magnetic Resonance Imaging 24 Hours After Tissue-Type Plasminogen Activator Administration
Stroke 44:2776-2781, Kimura, K.,et al, 2013
Thrombolysis for Ischemic Stroke Associated with Infective Endocarditis
Stroke 44:2917-2919, Asaithambi, G.,et al, 2013
Clinicopathologic Conference, Acute Infectious Mononucleosis due to Epstein-Barr Virus Infection, Complicated by Acute Otitis Media and Postinfectious Cerebellitis
NEJM 369:1253-1261, Case 30-2013, 2013
Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients Treated with Warfarin
Ann Neurol 74:266-274, Mazya, M.V.,et al, 2013
Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage after Intravenous Tissue Plasminogen Activator (IV tPA)
Medicine 92:317-323, Marsh, E.B.,et al, 2013
IV Thrombolysis and Renal Function
Neurol 81:1780-1788, Gensicke, H.,et al, 2013
Thrombolysis for Acute Ischemic Stroke in Patients with Cancer
Stroke 44:3573-3576, Murthy, S.B.,et al, 2013
Ischemic Stroke after Use of the Synthetic Marijuana "Spice"
Neurol 81:2090-2093, Freeman, M.J.,et al, 2013
Glycosylated Hemoglobin A1 Predicts Risk for Symptomatic Hemorrhage After Thrombolysis for Acute Stroke
Stroke 44:2134-2138, Rocco, A.,et al, 2013
Aspergillus Meningitis: A Rare Clinical Manifestation of Central Nervous System Aspergillosis
J Infect 66:218-238, Antinori, S.,et al, 2013
Delayed Onset of Progressive Chorea After Acute Basal Ganglia Injury
Mov Disord 28:585-587, Virmani, T.,et al, 2013
What is Meant by "TICI"?
AJNR 34:1792-1797, Fugate,J.E.,et al, 2013
Treatment of Multiple System Atrophy Using Intravenous Immunoglobulin
BMC Neurol 12:131, Novak, P.,et al, 2012
Management of Anticoagulation Before and After Elective Surgery
www.uptodate.com Dec. 2012, Lip, G. & Douketis, J., 2012
The Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients with Pre-Existing Cerebral Aneurysms
Stroke 43:412-416, Edwards,N.J.,et al, 2012
Stiff-Man Syndrome and Variants
Arch Neurol 69:230-238, McKeon,A.,et al, 2012
Solitaire Flow Restoration Device Versus the Merci Retriever in Patients with Acute Ischaemic Stroke (SWIFT): a Randomised, Parallel-Group, Non-Inferiority Trial
Lancet 380:1241-1249,1208, Saver, J.L.,et al, 2012
Trevo Versus Merci Retrievers for Thrombectomy Revascularisation of Large Vessel Occlusions in Acute Ischaemic Stroke (TREVO 2): A Randomised Trial
Lancet 380:1231-1240,1208, Nogueira, R.G.,et al, 2012
Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 43:2904-2909, Whiteley, W.N.,et al, 2012
Time is Brain(stem) in Basilar Artery Occlusion
Stroke 43:3003-3006, Vergouwen, M.D.I.,et al, 2012
Smartphone Teleradiology Application is Succesfully Incorporated Into a Telestroke Network Environment
Stroke 43:3098-3101, Demaerschalk, B.M.,et al, 2012
Fluid-Attenuated Inversion Recovery Vascular Hyperintensity
Arch Neurol 69:1462-1468, Olindo, S.,et al, 2012
Infarct Volume is a Pivotal Biomarker After Inter-Arterial Stroke Therapy
Stroke 43:1323-1330, Yoo,A.J.,et al, 2012
Bridging Therapy in Acute Ischemic Stroke
Stroke 43:1302-1308, Mazighi,M.,et al, 2012
Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis: The SEDAN Score
Ann Neurol 71:634-641, Strbian,D.,et al, 2012
Update on the Pathophysiology and Management of Idiopathic Intracranial Hypertension
JNNP 83:488-494, Biousse,V.,et al, 2012
Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders
Neurol 78:1009-1015, Patwa,H.S.,et al, 2012
Electrophysiological Study with Prophylactic Pacing and Survival in Adults with Myotonic Dystrophy and Conduction System Disease
JAMA 307:1292-1301, Wahbi,K.,et al, 2012
A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke
NEJM 366:1099-1107, Parsons,M.,et al, 2012
Requirements for Emergent Neurosurgical Procedures among Patients Undergoing Neuroendovascular Procedures in Contemporary Practice
AJNR 33:465-468, Khatri,R.,et al, 2012
Acute Symptomatic Seizures
The Neurologist 18:109-119, Beleza,P., 2012
Autoimmune Epilepsy
Arch Neurol 69:582-593,565, Quek, A.M.L.,et al, 2012
Acute Stroke Imaging: What is Sufficient for Triage to Endovascular Therapies?
AJNR 33:790-792, Lev, M.H., 2012
Factors Influencing In-Hospital Delay in Treatment with Intravenous Thrombolysis
Stroke 43:1578-1583, Mikulik, R.,et al, 2012
Guillain-Barre Syndrome
NEJM 366:2294-2304, Yuki, N. & Hartung, H.P., 2012
Intracranial Dural Arteriovenous Fistulas: Classification, Imaging Findings, and Treatment
AJNR 33:1007-1013, Gandhi, D.,et al, 2012
Endoscopic Treatment of Hydrocephalus
Arch Neurol 69:664, Walcott, B.P.,et al, 2012
Immunotherapy-Responsive Chorea as the Presenting Feature of LGI1-Antibody Encephalitis
Neurol 79:195-196, Tofaris,G.K.,et al, 2012
The Benefits and Harms of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator within 6 h of Acute Ischaemic Stroke (the third international stroke trial IST-3): a Randomised Controlled Trial
Lancet 379: 2320, IST-3 collaborative group, 2012
Recombinant Tissue Plasminogen Activator for Acute Ischaemic Stroke: An Updated Systematic Review and Meta-Analysis
Lancet 379: 2364-2372, Wardlaw, J.M.,et al, 2012